Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3875535
Reference Type
Journal Article
Title
Effects of IMAGENT on pulmonary hemodynamics and gas exchange in dogs
Author(s)
Kirkton, SD; Wagner, H; Landicho, MM; Struthers, JJ; Busan, N; Wagner, PD
Year
2006
Is Peer Reviewed?
1
Journal
Ultrasound in Medicine & Biology
ISSN:
0301-5629
EISSN:
1879-291X
Publisher
ELSEVIER SCIENCE INC
Location
NEW YORK
Volume
32
Issue
6
Page Numbers
949-959
Language
English
PMID
16785016
DOI
10.1016/j.ultrasmedbio.2006.02.1422
Web of Science Id
WOS:000238557800017
Abstract
Imagent is an IV injected contrast echocardiography agent designed to image the left ventricle after traversing the pulmonary circulation. We examined the effect of Imagent on pulmonary function by injecting either Imagent (n = 8) or equivalent volume of saline (n = 7) IV in randomly ordered 1, 8 and 16 mg/kg doses in dogs with preexisting pulmonary hypertension. We found that Imagent had no effects on cardiac output, pulmonary gas exchange, lung wet:dry ratio or static compliance. However, the 16 mg/kg dose of Imagent increased both pulmonary artery pressure (PAP) transiently by an average of 5.7 mmHg (p < 0.05) 2 to 3 min after injection and pulmonary vascular resistance (PVR) by 5.9 mmHg per l/min (p < 0.05) 4 min after injection before returning to preinjection levels. The lower doses of Imagent did not affect PAP or PVR. These results imply that the approved clinical dose of Imagent (0.125 mg/kg) will not affect pulmonary hemodynamics, gas exchange or mechanical properties in dogs with preexisting pulmonary hypertension.
Keywords
Animals; Blood Pressure/drug effects; Contrast Media/pharmacokinetics/pharmacology; Fluorocarbons/pharmacokinetics/pharmacology; Hydrocarbons, Brominated/pharmacokinetics/pharmacology; Lung/metabolism; Lung Compliance/drug effects; Microspheres; Pulmonary Artery/physiology; Pulmonary Circulation/drug effects; Pulmonary Gas Exchange/drug effects
Tags
PFAS
•
6:2 diPAP
Literature Search
Pubmed
Screening Results
Excluded/Not on Topic
•
8:2 diPAP
Literature Search
Pubmed
Screening Results
Excluded/Not on Topic
•
Additional PFAS (formerly XAgency)
•
^Per- and Polyfluoroalkyl Substances (PFAS)
6:2 diPAP (57677-95-9)
Literature Search
Pubmed
8:2 diPAP (678-41-1)
Literature Search
Pubmed
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity